102 related articles for article (PubMed ID: 1385993)
1. Leukemic phase of intermediate non-Hodgkin's lymphoma with cells showing different matured stages in invaded various organs.
Shimamoto T; Ohyashiki K; Nehashi Y; Tauchi T; Ohyashiki JH; Toyama K
Intern Med; 1992 Apr; 31(4):553-6. PubMed ID: 1385993
[TBL] [Abstract][Full Text] [Related]
2. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
3. Immunophenotypic evaluation of the bone marrow in non-Hodgkin's lymphoma.
Fineberg S; Marsh E; Alfonso F; Espiritu E; Gottesman SR; Amorosi E; Feiner HD
Hum Pathol; 1993 Jun; 24(6):636-42. PubMed ID: 8505041
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric immunophenotyping analysis of patterns of antigen expression in non-Hodgkin's B cell lymphoma in samples obtained from different anatomic sites.
Gervasi F; Lo Verso R; Giambanco C; Cardinale G; Tomaselli C; Pagnucco G
Ann N Y Acad Sci; 2004 Dec; 1028():457-62. PubMed ID: 15650271
[TBL] [Abstract][Full Text] [Related]
5. Adhesion molecule expression in CD5-negative/CD10-negative chronic B-cell leukemias: comparison with non-Hodgkin's lymphomas and CD5-positive B-cell chronic lymphocytic leukemia.
Finn WG; Singleton TP; Schnitzer B; Ross CW; Stoolman LM
Hum Pathol; 2001 Jan; 32(1):66-73. PubMed ID: 11172297
[TBL] [Abstract][Full Text] [Related]
6. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
7. Leukemic phase of mantle cell lymphoma presenting as anemia: diagnosis by combining flow cytometry and cytomorphology.
Brink DS; Grosso LE; Dunphy CH
Arch Pathol Lab Med; 1998 Nov; 122(11):1018-22. PubMed ID: 9822132
[TBL] [Abstract][Full Text] [Related]
8. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
Matolcsy A; Chadburn A; Knowles DM
Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
[TBL] [Abstract][Full Text] [Related]
9. Splenic lymphoma with villous lymphocytes with CD5+, CD11c+ B-cell phenotype.
Miyawaki S; Machii T; Hirabayashi H; Sakura T; Shiozaki H; Yashiro K; Murakami H; Tsuchiya J; Kashiwabara K; Kitani T
Intern Med; 1993 Jun; 32(6):472-5. PubMed ID: 7694693
[TBL] [Abstract][Full Text] [Related]
10. MY4 expression on B-lymphocyte malignancies may be associated with a more adverse prognosis.
Warzynski MJ; Otto RN; Steingart RH; White CF; Rosen MH; Hetzel PC; Flatow FA; Podgurski AE; Johnson ML
Leuk Res; 1991; 15(5):357-65. PubMed ID: 2046387
[TBL] [Abstract][Full Text] [Related]
11. The CD24 antigen discriminates between pre-B and B cells in human bone marrow.
Duperray C; Boiron JM; Boucheix C; Cantaloube JF; Lavabre-Bertrand T; Attal M; Brochier J; Maraninchi D; Bataille R; Klein B
J Immunol; 1990 Dec; 145(11):3678-83. PubMed ID: 1700990
[TBL] [Abstract][Full Text] [Related]
12. Follicular lymphoma of compartmentalized small cleaved center cells and mantle zone lymphocytes. Evidence for a common derivation.
Carbone A; Gloghini A; Volpe R; Attadia V; Gattei V; Zagonel V; Pinto A
Am J Clin Pathol; 1992 Oct; 98(4):437-48. PubMed ID: 1384307
[TBL] [Abstract][Full Text] [Related]
13. Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases.
Chow KU; Sommerlad WD; Boehrer S; Schneider B; Seipelt G; Rummel MJ; Hoelzer D; Mitrou PS; Weidmann E
Haematologica; 2002 Jan; 87(1):33-43. PubMed ID: 11801463
[TBL] [Abstract][Full Text] [Related]
14. Effect of alemtuzumab on neoplastic B cells.
Golay J; Manganini M; Rambaldi A; Introna M
Haematologica; 2004 Dec; 89(12):1476-83. PubMed ID: 15590398
[TBL] [Abstract][Full Text] [Related]
15. An unusual case of leukemic non-Hodgkin's lymphoma with blastic transformation.
Späth-Schwalbe E; Flath B; Kaufmann O; Thiel G; Brinckmann R; Dietel M; Possinger K
Ann Hematol; 2000 Apr; 79(4):217-21. PubMed ID: 10834510
[TBL] [Abstract][Full Text] [Related]
16. Monocytoid B-cell lymphoma with a distinctive clinical presentation.
Vasef M; Katzin WE
Hum Pathol; 1993 May; 24(5):558-61. PubMed ID: 8491494
[TBL] [Abstract][Full Text] [Related]
17. Leukemic phase of B-cell lymphomas mimicking chronic lymphocytic leukemia and variants at presentation.
Nelson BP; Variakojis D; Peterson LC
Mod Pathol; 2002 Nov; 15(11):1111-20. PubMed ID: 12429788
[TBL] [Abstract][Full Text] [Related]
18. Immunobiologic differences between normal and leukemic human B-cell precursors.
Uckun FM; Ledbetter JA
Proc Natl Acad Sci U S A; 1988 Nov; 85(22):8603-7. PubMed ID: 2460871
[TBL] [Abstract][Full Text] [Related]
19. Transformation of chronic lymphocytic leukemia to small non-cleaved cell lymphoma: a cytogenetic, immunological, and molecular study.
Litz CE; Arthur DC; Gajl-Peczalska KJ; Rausch D; Copenhaver C; Coad JE; Brunning RD
Leukemia; 1991 Nov; 5(11):972-8. PubMed ID: 1961039
[TBL] [Abstract][Full Text] [Related]
20. Splenic lymphoma with circulating villous lymphocytes/splenic marginal-zone lymphoma.
Catovsky D; Matutes E
Semin Hematol; 1999 Apr; 36(2):148-54. PubMed ID: 10319383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]